Earnings History Data for MiNK Therapeutics, Inc. (INKT) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
MiNK Therapeutics, Inc.
MiNK Therapeutics Inc. is a clinical stage biotechnology company pioneering the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant natural killer T cell therapies to treat cancer and other immune-mediated diseases. MiNK Therapeutics Inc. is headquartered in New York.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14-11-2024 | PM | INKT | MiNK Therapeutics, Inc. | 30.84 | -0.05 | -0.08 | -0.15 | MiNK Therapeutics GAAP EPS of -$0.05 [11/14/2024 9:57 AM] |
0.7719 | -0.02 (-2.83%) |
0.84 | 0.04 (5.48%) |
0.57 - 1.90 | 18,308 | 40,000 | 7,663 | ||
| 13-08-2024 | PM | INKT | MiNK Therapeutics, Inc. | 28.00 | -0.07 | -0.10 | 0.00 | MiNK Therapeutics GAAP EPS of -$0.07 beats by $0.02 [8/13/2024 7:24 AM] |
0.8472 | 0.01 (1.46%) |
0.84 | 0.0 (0.59%) |
0.75 - 1.90 | 51,017 | 50,000 | 3,815 | ||
| 14-05-2024 | PM | INKT | MiNK Therapeutics, Inc. | 31.23 | -0.11 | -0.16 | -0.17 | MiNK Therapeutics reports Q1 results [5/14/2024 10:25 AM] |
1.14 | 0.16 (16.35%) |
0.97 | -0.01 (-1.00%) |
0.75 - 3.34 | 565,454 | 510,000 | 36,672 | ||
| 21-03-2024 | PM | INKT | MiNK Therapeutics, Inc. | 29.69 | -0.16 | -0.15 | -0.23 | MiNK Therapeutics GAAP EPS of -$0.16 misses by $0.01 [3/21/2024 7:26 AM] |
0.89 | -0.01 (-0.67%) |
0.89 | 0.0 (-0.56%) |
0.75 - 3.34 | 41,861 | 50,000 | 3,505 | ||
| 09-11-2023 | PM | INKT | MiNK Therapeutics, Inc. | 39.68 | -0.15 | -0.18 | -0.19 | MiNK Therapeutics GAAP EPS of -$0.15 [11/9/2023 12:46 PM] |
1.09 | -0.09 (-7.98%) |
0.0 | 0.0 (0.00%) |
0.85 - 3.42 | 30,918 | 40,000 | 0 | ||
| 10-08-2023 | PM | INKT | MiNK Therapeutics, Inc. | 63.68 | -0.18 | -0.19 | -0.18 | MiNK Therapeutics GAAP EPS of -$0.18 [8/10/2023 10:29 AM] |
1.92 | 0.12 (6.67%) |
1.87 | 0.07 (3.89%) |
0.85 - 4.32 | 140,193 | 60,000 | 1,447 | ||
| 11-05-2023 | AH | 8:00 AM ET (May 11) |
INKT | MiNK Therapeutics, Inc. | 57.31 | -0.17 | -0.24 | -0.23 | MiNK Therapeutics GAAP EPS of -$0.22 beats by $0.02, revenue of $22.9M [5/10/2023 5:41 PM] |
1.60 | 0.09 (5.96%) |
1.45 | -0.06 (-3.97%) |
0.85 - 4.32 | 245,221 | 530,000 | 11,529 | |
| 21-03-2023 | PM | 8:00 AM ET (Mar 21) |
INKT | MiNK Therapeutics, Inc. | 67.57 | -0.23 | -0.21 | -0.18 | MiNK Therapeutics GAAP EPS of $0.23 [3/21/2023 8:59 AM] |
2.04 | -0.04 (-1.85%) |
0.0 | 0.0 (0.00%) |
1.09 - 4.32 | 19,715 | 20,000 | 0 | |
| 03-11-2022 | PM | 8:00 AM ET (Nov 3) |
INKT | MiNK Therapeutics, Inc. | 75.32 | -0.19 | -0.23 | -0.59 | MiNK Therapeutics GAAP EPS of $0.19 [11/3/2022 8:03 AM] |
2.23 | 0.10 (4.69%) |
0.0 | 0.0 (0.00%) |
1.09 - 21.40 | 20,616 | 10,000 | 0 | |
| 09-08-2022 | PM | 8:00 AM ET (Aug 9) |
INKT | MiNK Therapeutics, Inc. | 46.31 | -0.18 | -0.24 | 0.00 | MiNK Therapeutics GAAP EPS of -$0.18 [8/9/2022 8:07 AM] |
1.32 | -0.04 (-2.94%) |
0.0 | 0.0 (0.00%) |
1.09 - 22.16 | 106,097 | 50,000 | 0 | |
| 10-05-2022 | PM | 8:30 AM ET (May 10) |
INKT | MiNK Therapeutics, Inc. | 65.40 | -0.23 | -0.21 | 0.00 | MiNK Therapeutics GAAP EPS of -$0.23 [5/10/2022 8:09 AM] |
1.65 | -0.11 (-6.25%) |
0.0 | 0.0 (0.00%) |
1.66 - 22.16 | 26,868 | 65,841 | 0 | |
| 18-03-2022 | PM | 0:00 AM ET (Mar 18) |
INKT | MiNK Therapeutics, Inc. | 76.05 | -0.18 | -0.24 | 0.00 | MiNK Therapeutics GAAP EPS of -$0.18 beats by $0.23 [3/18/2022 8:37 AM] |
3.16 | 0.06 (1.94%) |
2.93 | -0.17 (-5.48%) |
2.16 - 22.16 | 175,634 | 80,681 | 250 | |